Mesangial cell Fas ligand: Upregulation in human lupus nephritis and NF-κB-mediated expression in cultured human mesangial cells

Clinical and Experimental Nephrology

Volumn 8, Issue 3, 2004, Pages 196-205

  Tsukinoki, Tomoko ^a   Sugiyama, Hitoshi ^a   Sunami, Reiko ^a   Kobayashi, Mizuho ^a   Onoda, Tetsuya ^a   Maeshima, Yohei ^a   Yamasaki, Yasushi ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Interleukin 1 ; Lupus; Matrix metalloproteinase; Nuclear factor B; Soluble Fas ligand

Indexed keywords

CYTOKINE; FAS LIGAND; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1BETA; LACTACYSTIN; LIPOPOLYSACCHARIDE; MATRILYSIN; SOLUBLE FAS LIGAND; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CONFOCAL LASER MICROSCOPY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULONEPHRITIS; HEMATURIA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY DYSFUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MESANGIUM CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEINURIA; SCORING SYSTEM; UPREGULATION;

ACETYLCYSTEINE; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; CYTOKINES; DISEASE PROGRESSION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; GLOMERULAR MESANGIUM; HUMANS; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; LUPUS NEPHRITIS; MATRIX METALLOPROTEINASE 7; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; NF-KAPPA B; NUCLEAR PROTEINS; UP-REGULATION;

EID: 7044226361     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-004-0301-3     Document Type: Article

References (33)

1. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
2. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
3. Borges VM, falcao H, Leite-Junior JH, Alvim L, Teixeira GP, Russo M, et al. Fas ligand triggers pulmonary silicosis. J Exp Med 2001;194:155-64.
4. Rescigno M, Piguet V, Valzasina B, Lens S, Zubler R, french L, et al. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1 beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J Exp Med 2000;192:1661-8.
5. O'Connell J, Houston A, Bennett MW, O'Sullivan GC, Shanahan F. Immune privilege or inflammation? Insights into the Fas ligand enigma. Nat Med 2001;7:271-4.
6. Lorz C, Ortiz A, Justo P, Gonzalez-Cuadrado S, Duque N, Gomez-Guerrero C, et al. Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol 2000;11:1266-77.
7. Badillo-Almaraz I. Daza L, Avalos-Diaz E, Herrera-Esparza R. Glomerular expression of Fas ligand and Bax mRNA in lupus nephritis. Autoimmunity 2001;34:283-9.
8. Churg J, Bernstein J, Glassock R. Lupus nephritis. In Churg J, Bernstein J, Glassock R, editors. Renal diseases, classification of atlas of glomerular diseases. New York: Igaku-shoin; 1995, p. 151.
9. Austin HA, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, et al. Prognostic factors in lupus nephritis: contribution of renal histologic data. Am J Med 1983;75:382-91.
10. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z. Apoptosis in glomerular sclerosis. Kidney Int 1996;49:103-11.
11. Sugiyama H, Kashihara N, Onbe T, Yamasaki Y, Wada J, Sekikawa T, et al. Bcl-2 expression and apoptosis in nephrotoxic nephritis. Exp Nephrol 1997;5:481-9.
12. Makino H, Sugiyama H, Yamasaki Y, Maeshima Y, Wada J, Kashihara N. Glomerular cell apoptosis in human lupus nephritis. Virchows Arch 2003;443:67-77.
13. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z. Reactive oxygen species induce apoptosis in cultured human mesangial cells. J Am Soc Nephrol 1996;7:2357-63.
14. Moriwaki M, Itoh N, Miyagawa J, Yamamoto K, Imagawa A, Yamagata K, et al. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with rcent-onset Type I diabetes mellitus. Diabetologia 1999;42:1332-40.
15. Sugiyama H, Kashihara N, Maeshima Y, Okamoto K, Kanao K, Sekikawa T, et al. Regulation of survival and death of mesangial cells by extracellular matrix. Kidney Int 1998;54:1188-96.
16. Stylianou E, O'Neill LA, Rawlinson L, Edbrooke MR, Woo P, Saklatvala J. Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. J Biol Chem 1992;267:15836-41.
17. Sugiyama H, Savill J, Kitamura M, Zhao L, Stylianou E. Selective sensitization to tumor necrosis factor-alpha-induced apoptosis by blockade of NF-kappaB in primary glomerular mesangial cells. J Biol Chem 1999;274:19 532-7.
18. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, et al. Fas ligand in human serum. Nat Med 1996;2:317-22.
19. Li-Weber M, Krammer PH. The death of a T-cell: expression of the CD95 ligand. Cell Death Differ 2002;9:101-3.
20. Sakata N, Stoops JD, Dixon JL. Cytosolic components are required for proteasomal degradation of newly synthesized apolipoprotein B in permeabilized HepG2 cells. J Biol Chem 1999;274:17068-74.
21. Chow WA, Fang JJ, Yee JK. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. J Immunol 2000;164:3512-8.
22. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med 1997;186:2045-50.
23. Tanaka M, Itai T, Adachi M, Nagata S. Downregulation of Fas ligand by shedding. Nat Med 1998;4:31-6.
24. Miwa K, Asano M, Horai R, Iwakura Y, Nagata S, Suda T. Caspase 1-independent IL-1 beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med 1998;4:1287-92.
25. Mitsiades N, Poulaki V, Mitsiades CS, Koutras DA, Chrousos GP. Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases. Trends Endocrinol Metab 2001;12:384-90.
26. Takemura T, Murakami K, Miyazato H, Yagi K, Yoshioka K. Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int 1995;48:1886-92.
27. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994;94:2015-16.
28. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N. Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 1995;47:114-21.
29. Itoh, J, Nose M, Takahashi S, Ono M, Terasaki S, Kondoh E, et al. Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/lpr lupus mouse. Am J pathole 1993;143:1436-43.
30. Hiramatsu N, Kasai A, Yao J, Meng Y, Takeda M, Maeda S, et al. AP-1-independent sensitization to oxidative stress-induced apoptosis by proteasome inhibitors. Biochem Biophys Res Commun 2004;316:545-52.
31. Akiyama K, Shikata K, Sugimoto H, Matsuda M, Shikata Y, Fujimoto N, et al. Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis. Res Commun Mol Pathol Pharmacol 1997;95:115-28.
32. Matsuno H, Yudoh K, Watanabe Y, Nakazawa F, Aono H, Kimura T. Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand. J Rheumatol 2001;28:22-8.
33. Shudo K, Kinoshita K, Imamura R, Fan H, Hasumoto K, Tanaka M, et al. The membrane-bound but not the soluble form of human Fas ligand is responsible for its inflammatory activity. Eur J Immunol 2001;31:2504-11.